Results 111 to 120 of about 15,553 (191)

Clin Infect Dis [PDF]

The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern.

core  

Erratum: Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis

Frontiers in Pharmacology, 2022
Frontiers Production Office
doaj   +1 more source

Iowa Board of Pharmacy News, March 2016 [PDF]

, 2016
The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug ...

core  

Adequacy of the Dosing and Infusion Time of Ceftazidime/Avibactam for the Treatment of Gram-Negative Bacterial Infections: A PK/PD Simulation Study

Infection and Drug Resistance
Yun Han,1,* Jianping Zhu,1,* Jieqiong Liu,2 Ying Zheng,2 Gang Liang,1 Yi Yang,1 Lingyan Yu,3 Zhenwei Yu,1 Gang Han1 1Research Center for Clinical Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, College of Pharmaceutical Sciences ...
Han Y, Zhu J, Liu J, Zheng Y, Liang G, Yang Y, Yu L, Yu Z, Han G   +8 more
doaj  

A prospective one-year microbiologic survey of combined pneumonia and respiratory failure [PDF]

, 2017
Fisher, Kristen, Juang, Paul, Kollef, Marin H, Micek, Scott T, Trupka, Tracy   +4 more
core   +2 more sources

The <i>bla_KPC-249</i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]

Front Cell Infect Microbiol
Li X, Feng Y, Wu X, Shen H, Shang S, Tang W, Hu F, Liang H.   +7 more
europepmc   +1 more source

High <i>in vitro</i> activity of aztreonam/avibactam against NDM-producing Enterobacterales with emerging resistance in <i>Escherichia coli</i> in the United States Mid-Atlantic region. [PDF]

Microbiol Spectr
Eklund E, Maruca T, Kruczynski K, Critchfield H, Murphy R, Keller E, Lee B, Patel A, Klein L, Torpey DA, Myers RA, Campodónico VL.   +11 more
europepmc   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

KPC-33 and ompK37 mutations: Unraveling the mechanism of ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae. [PDF]

PLoS One
Zhao S, Ye L, Song S, Sun J, Xu J, Jiang F, Kang H.   +6 more
europepmc   +1 more source

Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum β-lactamases in the UK: relatedness and resistance [PDF]

, 2018
Greenwood, Beckie, Hill, Robert, Hopkins, Katie L, Ivanov, Zdravko, Livermore, David M, Meunier, Danièle, Pike, Rachel, Turton, Jane F, Woodford, Neil   +8 more
core   +1 more source